| Document And Entity Information | Sep. 28, 2021 |
| Document Information [Line Items] | |
| Entity, Registrant Name | Statera BioPharma, Inc. |
| Document, Type | 8-K |
| Document, Period End Date | Sep. 28, 2021 |
| Entity, Incorporation, State or Country Code | DE |
| Entity, File Number | 001-32954 |
| Entity, Tax Identification Number | 20-0077155 |
| Entity, Address, Address Line One | 2537 Research Boulevard |
| Entity, Address, Address Line Two | Suite 201 |
| Entity, Address, City or Town | Fort Collins |
| Entity, Address, State or Province | CO |
| Entity, Address, Postal Zip Code | 80526 |
| City Area Code | 888 |
| Local Phone Number | 613-8802 |
| Title of 12(b) Security | Common stock, par value $0.005 |
| Trading Symbol | STAB |
| Security Exchange Name | NASDAQ |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity, Emerging Growth Company | false |
| Amendment Flag | false |
| Entity, Central Index Key | 0001318641 |
